Insider Trading History of Gannon Steven

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Gannon Steven since 2017. This trader's CIK number is 1643085. At the time of last reporting, Gannon Steven was the Officer of Xenon Pharmaceuticals Inc.. (stock ticker symbol XENE). Also see all insider trading activities at Xenon Pharmaceuticals Inc..

Note that in the past GANNON STEVEN also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Fusion Pharmaceuticals Inc. (FUSN) by Gannon Steven

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 FUSN 44,400 $90,131 0 $0 0 $0
2021 FUSN 12,000 $96,715 0 $0 0 $0

Yearly summary of insider trading at Xenon Pharmaceuticals Inc. (XENE) by Gannon Steven

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 XENE 0 $0 0 $0 5,144 $64,660
2017 XENE 15,000 $42,270 0 $0 0 $0


Insider trading activities at 2 companies by Gannon Steven:

1. Fusion Pharmaceuticals Inc. (FUSN)

2. Xenon Pharmaceuticals Inc. (XENE)

Table 1. Insider trading of Fusion Pharmaceuticals Inc. (FUSN) by Gannon Steven

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-08-11 FUSN Buy 44,400 2.03 90,131
2021-08-23 FUSN Buy 2,829 7.99 22,589
2021-08-18 FUSN Buy 171 8.05 1,376
2021-08-19 FUSN Buy 3,000 8.05 24,150
2021-08-16 FUSN Buy 6,000 8.10 48,600

Table 2. Insider trading of Xenon Pharmaceuticals Inc. (XENE) by Gannon Steven

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-05-14 XENE Option Ex 5,144 12.57 64,660
2017-08-11 XENE Buy 15,000 2.82 42,270

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gannon Steven (Officer of Xenon Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.